相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives
Arash Soltani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
mTOR Inhibition and Cardiovascular Diseases: Dyslipidemia and Atherosclerosis
Ammar Kurdi et al.
TRANSPLANTATION (2018)
LJ-1888, a selective antagonist for the A(3) adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice
Jong-Gil Park et al.
BMB REPORTS (2018)
Sirolimus Therapy Is Associated with Elevation in Circulating PCSK9 Levels in Cardiac Transplant Patients
Vinaya Simha et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2017)
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease
Stephen Zewinger et al.
EUROPEAN HEART JOURNAL (2017)
The immunology of atherosclerosis
Anton Gistera et al.
NATURE REVIEWS NEPHROLOGY (2017)
mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells
Walaa Eid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Potential therapeutic effects of mTOR inhibition in atherosclerosis
Ammar Kurdi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia
Mary E. Haas et al.
CIRCULATION (2016)
Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP
Xiaoqi Zhao et al.
MEDIATORS OF INFLAMMATION (2015)
Con: Vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease
Carmine Zoccali et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
mTOR inhibition: A promising strategy for stabilization of atherosclerotic plaques
Wim Martinet et al.
ATHEROSCLEROSIS (2014)
Atorvastatin Protects Vascular Smooth Muscle Cells From TGF-β1-Stimulated Calcification by Inducing Autophagy via Suppression of the β-Catenin Pathway
Demin Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Disruption of Mammalian Target of Rapamycin Complex 1 in Macrophages Decreases Chemokine Gene Expression and Atherosclerosis
Ding Ai et al.
CIRCULATION RESEARCH (2014)
An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E-/- mice
Nan Peng et al.
SCIENTIFIC REPORTS (2014)
Adverse events associated with mTOR inhibitors
Nicolas Pallet et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification
Jane L. Finch et al.
KIDNEY INTERNATIONAL (2013)
Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies
Wijtske Annema et al.
NUTRITION & METABOLISM (2012)
Anti-Inflammatory Effect of Amlodipine Plus Atorvastatin Treatment on Carotid Atherosclerosis in Zucker Metabolic Syndrome Rats
Xuemei Zhang et al.
TRANSLATIONAL STROKE RESEARCH (2012)
Atorvastatin Reduces Calcification in Rat Arteries and Vascular Smooth Muscle Cells
Huan Li et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
Chronic Rapamycin Treatment Causes Glucose Intolerance and Hyperlipidemia by Upregulating Hepatic Gluconeogenesis and Impairing Lipid Deposition in Adipose Tissue
Vanessa P. Houde et al.
DIABETES (2010)
Chronic Uremia Stimulates LDL Carbamylation and Atherosclerosis
Eugene O. Apostolov et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Focused Atorvastatin Therapy in Managed-Care Patients With Coronary Heart Disease and CKD
Michael J. Koren et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Cytokine dysregulation in chronic kidney disease: How can we treat it?
Juan Jesus Carrero et al.
BLOOD PURIFICATION (2008)
Chronic kidney disease - Effects on the cardiovascular system
Ernesto L. Schiffrin et al.
CIRCULATION (2007)
Calcification and cardiovascular health - New insights into an old phenomenon
Markus Ketteler et al.
HYPERTENSION (2006)
IL-10, IL-6, and TNF-α:: Central factors in the altered cytokine network of uremia -: The good, the bad, and the ugly
P Stenvinkel et al.
KIDNEY INTERNATIONAL (2005)
ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation
MA Kennedy et al.
CELL METABOLISM (2005)
Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice
ZA Massy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse
JW Chisholm et al.
JOURNAL OF LIPID RESEARCH (2003)
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
J Himmelfarb et al.
KIDNEY INTERNATIONAL (2002)
LXRα is the dominant regulator of CYP7A1 transcription
S Gupta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Effect of sirolimus on the metabolism of ApoB100-containing lipoproteins in renal transplant patients
RC Hoogeveen et al.
TRANSPLANTATION (2001)
分享论文
